a nonsignificant trendP =.08
During the intervention period, no differences were observed in early weeks (weeks 1‐6; range of Ps= .11 to .95), but a nonsignificant trend emerged at week 7 ( P =.08) that became fully significant by weeks 8 and 9 (both Ps =.01), favoring faster symptom reduction in CBI-VR over CBI-FS and DAC.